Xeris Biopharma Holdings Inc. buy Piper Sandler
Start price
10.05.24
/
50%
€1.64
Target price
10.05.25
€2.78
Performance (%)
188.96%
End price
11.05.25
€4.74
Summary
This prediction ended on 11.05.25 with a price of €4.74. The BUY prediction by Piper_Sandler for Xeris Biopharma Holdings Inc. saw massive gains of 188.96%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | -0.251% | -0.251% | 84.178% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Piper_Sandler for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€1.60
10.11.23
10.11.23
€3.74
10.11.24
10.11.24
99.88%
11.11.24
11.11.24
